• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对HIV-1 gp120的中和性交叉反应和非中和性单克隆抗体

Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120.

作者信息

Akerblom L, Hinkula J, Broliden P A, Mäkitalo B, Fridberger T, Rosen J, Villacres-Eriksson M, Morein B, Wahren B

机构信息

Department of Veterinary Microbiology, Faculty of Veterinary Medicine, Biomedical Center, Uppsala, Sweden.

出版信息

AIDS. 1990 Oct;4(10):953-60. doi: 10.1097/00002030-199010000-00002.

DOI:10.1097/00002030-199010000-00002
PMID:1702001
Abstract

Amino acid sequences inducing neutralizing antibodies to HIV-1 were sought. Murine monoclonal antibodies (MAbs) were characterized by their reactivity with the envelope precursor gp160 or the Escherichia coli recombinant DNA products pB1 and pE3 representing the carboxy- and amino-terminal halves of mature envelope gp120. Fine mapping of the MAb determinants was performed using defined 15-mer synthetic peptides spanning the entire envelope gp120 region of HIV-1. One group of MAbs recognizes epitopes (amino acids 304-323) occurring in a small region with variable and conserved amino acid sequences of gp120. These MAbs mediate neutralization of the HIV-1 strain HTLV-IIIB (HIV-1IIIB) which was used for immunization. Nine out of 11 primary HIV-1 isolates were neutralized well or moderately well. In addition, prominent serological reactivity was noted with peptide sequences of strains of various European or American origins, but not with two HIV-1 strains of African origin. The cross-reactivity contrasts with previously described type-specific reactions to other sequences of this region. The reactivity to the short conserved site GPGR with its flanking amino acids may explain the broad sequence cross-reactivity seen with our neutralizing MAbs. Two other MAbs recognize conserved epitopes (amino acids 79-103) situated in the amino-terminal region of gp120. These MAbs did not neutralize HIV-1IIIB.

摘要

人们一直在寻找能诱导产生抗HIV-1中和抗体的氨基酸序列。鼠单克隆抗体(MAb)通过其与包膜前体gp160或代表成熟包膜gp120羧基端和氨基端的大肠杆菌重组DNA产物pB1和pE3的反应性来表征。使用跨越HIV-1包膜gp120整个区域的特定15聚体合成肽对MAb决定簇进行精细定位。一组MAb识别出现在gp120可变和保守氨基酸序列的一个小区域中的表位(氨基酸304 - 323)。这些MAb介导了用于免疫的HIV-1毒株HTLV-IIIB(HIV-1IIIB)的中和作用。11株原发性HIV-1分离株中有9株被中和得很好或较好。此外,观察到与各种欧美来源毒株的肽序列有显著的血清学反应性,但与两株非洲来源的HIV-1毒株没有反应。这种交叉反应性与先前描述的对该区域其他序列的型特异性反应形成对比。对短保守位点GPGR及其侧翼氨基酸的反应性可能解释了我们的中和MAb所见的广泛序列交叉反应性。另外两种MAb识别位于gp120氨基端区域的保守表位(氨基酸79 - 103)。这些MAb不能中和HIV-1IIIB。

相似文献

1
Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120.针对HIV-1 gp120的中和性交叉反应和非中和性单克隆抗体
AIDS. 1990 Oct;4(10):953-60. doi: 10.1097/00002030-199010000-00002.
2
Monoclonal antibodies to the extracellular domain of HIV-1IIIB gp160 that neutralize infectivity, block binding to CD4, and react with diverse isolates.针对HIV-1IIIB gp160细胞外结构域的单克隆抗体,这些抗体可中和感染性、阻断与CD4的结合并与多种分离株发生反应。
AIDS Res Hum Retroviruses. 1992 Nov;8(11):1875-85. doi: 10.1089/aid.1992.8.1875.
3
Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.通过中和及结合试验评估针对HIV-1包膜的单克隆抗体:一项国际合作。
AIDS. 1994 Feb;8(2):169-81.
4
A potent, neutralizing human monoclonal antibody against a unique epitope overlapping the CD4-binding site of HIV-1 gp120 that is broadly conserved across North American and African virus isolates.一种强效的、具有中和作用的人源单克隆抗体,针对与HIV-1 gp120的CD4结合位点重叠的独特表位,该表位在北美和非洲的病毒分离株中广泛保守。
AIDS Res Hum Retroviruses. 1993 Oct;9(10):985-96. doi: 10.1089/aid.1993.9.985.
5
Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain.用来自gp120第三可变区的合成肽产生的1型人类免疫缺陷病毒特异性单克隆抗体和组特异性多克隆中和抗体。
J Virol. 1992 Mar;66(3):1823-31. doi: 10.1128/JVI.66.3.1823-1831.1992.
6
Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120.用可溶性CD4-gp120复合物进行免疫接种,优先诱导针对gp120构象依赖性表位的中和抗1型人类免疫缺陷病毒抗体。
J Virol. 1994 Sep;68(9):5854-62. doi: 10.1128/JVI.68.9.5854-5862.1994.
7
Characterization of monoclonal antibodies to human immunodeficiency virus type 2 envelope glycoproteins.针对人类免疫缺陷病毒2型包膜糖蛋白的单克隆抗体的特性分析
AIDS Res Hum Retroviruses. 1994 Dec;10(12):1659-67. doi: 10.1089/aid.1994.10.1659.
8
Immunological reactivity of a human immunodeficiency virus type I derived peptide representing a consensus sequence of the GP120 major neutralizing region V3.一种代表HIV-1型病毒糖蛋白120主要中和区域V3共有序列的衍生肽的免疫反应性
Arch Virol. 1992;127(1-4):139-52. doi: 10.1007/BF01309580.
9
Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network.在未感染过牛痘的成年人中,先用重组牛痘病毒gp160进行初免,再用rgp160进行加强免疫,以增强1型人类免疫缺陷病毒中和抗体。美国国立过敏与传染病研究所艾滋病疫苗临床试验网络。
J Infect Dis. 1993 Mar;167(3):533-7. doi: 10.1093/infdis/167.3.533.
10
A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.一项关于具有天然和嵌合序列的合成HIV-1肽与津巴布韦、坦桑尼亚和瑞典HIV-1阳性血清反应性差异的调查。
AIDS. 1993 Jun;7(6):759-67. doi: 10.1097/00002030-199306000-00002.

引用本文的文献

1
Rational monoclonal antibody development to emerging pathogens, biothreat agents and agents of foreign animal disease: The antigen scale.针对新出现的病原体、生物威胁因子和外来动物疾病病原体的合理单克隆抗体开发:抗原规模。
Vet J. 2005 Sep;170(2):193-211. doi: 10.1016/j.tvjl.2004.04.021.
2
Stoichiometry of monoclonal antibody neutralization of T-cell line-adapted human immunodeficiency virus type 1.单克隆抗体对T细胞系适应的1型人类免疫缺陷病毒的中和化学计量学
J Virol. 1999 Oct;73(10):8364-70. doi: 10.1128/JVI.73.10.8364-8370.1999.
3
Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus.
细胞培养传代的猿猴免疫缺陷病毒的中和敏感性
J Virol. 1997 Oct;71(10):7895-902. doi: 10.1128/JVI.71.10.7895-7902.1997.
4
Peptides isolated from random peptide libraries on phage elicit a neutralizing anti-HIV-1 response: analysis of immunological mimicry.从噬菌体上的随机肽库中分离出的肽引发中和性抗HIV-1反应:免疫模拟分析。
Immunology. 1996 Dec;89(4):579-86. doi: 10.1046/j.1365-2567.1996.d01-772.x.
5
Conserved N-linked oligosaccharides of the C-terminal portion of human immunodeficiency virus type 1 gp120 and viral susceptibility to neutralizing antibodies.人类免疫缺陷病毒1型gp120 C末端保守的N-连接寡糖与病毒对中和抗体的敏感性
Arch Virol. 1996;141(11):2139-51. doi: 10.1007/BF01718221.
6
N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120.N-丁基脱氧野尻霉素介导的对人类免疫缺陷病毒进入的抑制作用与gp120的V1/V2区域抗体识别的变化相关。
J Virol. 1996 Oct;70(10):7143-52. doi: 10.1128/JVI.70.10.7143-7152.1996.
7
Sensitivity of HIV-1 to neutralization by antibodies against O-linked carbohydrate epitopes despite deletion of O-glycosylation signals in the V3 loop.
Arch Virol. 1996;141(2):291-300. doi: 10.1007/BF01718400.
8
The use of the clinical immunology laboratory.临床免疫学实验室的使用。
Clin Rev Allergy. 1994 Summer;12(2):125-49. doi: 10.1007/BF02802351.
9
Immunological evidence for interactions between the first, second, and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1.1型人类免疫缺陷病毒表面糖蛋白gp120第一、第二和第五保守结构域之间相互作用的免疫学证据。
J Virol. 1994 Nov;68(11):6836-47. doi: 10.1128/JVI.68.11.6836-6847.1994.
10
Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4.在HIV-1 gp120的V1环中鉴定出一种N-连接聚糖,其影响抗V3抗体和可溶性CD4的中和作用。
Arch Virol. 1994;139(3-4):253-61. doi: 10.1007/BF01310789.